会议报告：第38届国际抗病毒研究会议将于2025年3月17日至21日在美国拉斯维加斯举行。

IF 4.5 2区医学 Q1 PHARMACOLOGY & PHARMACY

Antiviral research Pub Date : 2025-07-03 DOI:10.1016/j.antiviral.2025.106222

Robert Jordan , Nancie M. Archin , Valeria Cagno , Joy Y. Feng , Haitao Guo , Lara J. Herrero , Zlatko Janeba , Nicholas A. Meanwell , Jennifer Moffat , Johan Neyts , Joana Rocha-Pereira , Kathie L. Seley-Radtke , Timothy P. Sheahan , Jessica R. Spengler , Stephen R. Welch , Xuping Xie , Hovakim Zakaryan , Luis M. Schang , David Durantel

{"title":"会议报告：第38届国际抗病毒研究会议将于2025年3月17日至21日在美国拉斯维加斯举行。","authors":"Robert Jordan , Nancie M. Archin , Valeria Cagno , Joy Y. Feng , Haitao Guo , Lara J. Herrero , Zlatko Janeba , Nicholas A. Meanwell , Jennifer Moffat , Johan Neyts , Joana Rocha-Pereira , Kathie L. Seley-Radtke , Timothy P. Sheahan , Jessica R. Spengler , Stephen R. Welch , Xuping Xie , Hovakim Zakaryan , Luis M. Schang , David Durantel","doi":"10.1016/j.antiviral.2025.106222","DOIUrl":null,"url":null,"abstract":"<div><div>The 38th International Conference on Antiviral Research (ICAR), sponsored by the International Society for Antiviral Research (ISAR), took place March 17–21, 2025 in Las Vegas, Nevada, USA. The annual meeting brought together leading scientists from across academia, industry, and government to present the latest advances in antiviral research. Topics included discovery and development of novel antiviral agents, innovative therapeutic approaches, vaccine technologies, host-targeted strategies, and responses to emerging and re-emerging viral threats. ICAR 2025 featured keynote talks, short oral presentations, poster sessions and special sessions to encourage discussions between attendees and foster interdisciplinary collaboration. Several events were held to support the next generation of antiviral researchers, including dedicated sessions and networking opportunities focused on mentorship and career development for students, postdoctoral fellows, and early-career scientists. Importantly, ISAR continues to serve as a cornerstone for international collaboration and innovation in antiviral science, and the society is eager to continue these efforts at the 39th ICAR, to be held in Prague, Czech Republic, from April 27–May 1, 2026.</div></div>","PeriodicalId":8259,"journal":{"name":"Antiviral research","volume":"241 ","pages":"Article 106222"},"PeriodicalIF":4.5000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17–21, 2025\",\"authors\":\"Robert Jordan , Nancie M. Archin , Valeria Cagno , Joy Y. Feng , Haitao Guo , Lara J. Herrero , Zlatko Janeba , Nicholas A. Meanwell , Jennifer Moffat , Johan Neyts , Joana Rocha-Pereira , Kathie L. Seley-Radtke , Timothy P. Sheahan , Jessica R. Spengler , Stephen R. Welch , Xuping Xie , Hovakim Zakaryan , Luis M. Schang , David Durantel\",\"doi\":\"10.1016/j.antiviral.2025.106222\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The 38th International Conference on Antiviral Research (ICAR), sponsored by the International Society for Antiviral Research (ISAR), took place March 17–21, 2025 in Las Vegas, Nevada, USA. The annual meeting brought together leading scientists from across academia, industry, and government to present the latest advances in antiviral research. Topics included discovery and development of novel antiviral agents, innovative therapeutic approaches, vaccine technologies, host-targeted strategies, and responses to emerging and re-emerging viral threats. ICAR 2025 featured keynote talks, short oral presentations, poster sessions and special sessions to encourage discussions between attendees and foster interdisciplinary collaboration. Several events were held to support the next generation of antiviral researchers, including dedicated sessions and networking opportunities focused on mentorship and career development for students, postdoctoral fellows, and early-career scientists. Importantly, ISAR continues to serve as a cornerstone for international collaboration and innovation in antiviral science, and the society is eager to continue these efforts at the 39th ICAR, to be held in Prague, Czech Republic, from April 27–May 1, 2026.</div></div>\",\"PeriodicalId\":8259,\"journal\":{\"name\":\"Antiviral research\",\"volume\":\"241 \",\"pages\":\"Article 106222\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antiviral research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0166354225001482\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antiviral research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0166354225001482","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

摘要

由国际抗病毒研究学会（ISAR）主办的第38届国际抗病毒研究会议（ICAR）于2025年3月17日至21日在美国内华达州拉斯维加斯举行。这次年度会议汇集了来自学术界、工业界和政府的主要科学家，介绍了抗病毒研究的最新进展。主题包括发现和开发新型抗病毒药物、创新治疗方法、疫苗技术、针对宿主的策略以及对新出现和再次出现的病毒威胁的反应。ICAR 2025以主题演讲、简短的口头报告、海报会议和特别会议为特色，鼓励与会者之间的讨论，促进跨学科合作。为支持下一代抗病毒研究人员举行了几次活动，包括专门的会议和交流机会，重点关注学生、博士后研究员和早期职业科学家的指导和职业发展。重要的是，ISAR继续作为抗病毒科学国际合作和创新的基石，该协会渴望在将于2026年4月27日至5月1日在捷克共和国布拉格举行的第39届ICAR上继续这些努力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17–21, 2025

The 38th International Conference on Antiviral Research (ICAR), sponsored by the International Society for Antiviral Research (ISAR), took place March 17–21, 2025 in Las Vegas, Nevada, USA. The annual meeting brought together leading scientists from across academia, industry, and government to present the latest advances in antiviral research. Topics included discovery and development of novel antiviral agents, innovative therapeutic approaches, vaccine technologies, host-targeted strategies, and responses to emerging and re-emerging viral threats. ICAR 2025 featured keynote talks, short oral presentations, poster sessions and special sessions to encourage discussions between attendees and foster interdisciplinary collaboration. Several events were held to support the next generation of antiviral researchers, including dedicated sessions and networking opportunities focused on mentorship and career development for students, postdoctoral fellows, and early-career scientists. Importantly, ISAR continues to serve as a cornerstone for international collaboration and innovation in antiviral science, and the society is eager to continue these efforts at the 39th ICAR, to be held in Prague, Czech Republic, from April 27–May 1, 2026.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Antiviral research 医学-病毒学

CiteScore

17.10

自引率

3.90%

发文量

157

审稿时长

34 days

期刊介绍： Antiviral Research is a journal that focuses on various aspects of controlling viral infections in both humans and animals. It is a platform for publishing research reports, short communications, review articles, and commentaries. The journal covers a wide range of topics including antiviral drugs, antibodies, and host-response modifiers. These topics encompass their synthesis, in vitro and in vivo testing, as well as mechanisms of action. Additionally, the journal also publishes studies on the development of new or improved vaccines against viral infections in humans. It delves into assessing the safety of drugs and vaccines, tracking the evolution of drug or vaccine-resistant viruses, and developing effective countermeasures. Another area of interest includes the identification and validation of new drug targets. The journal further explores laboratory animal models of viral diseases, investigates the pathogenesis of viral diseases, and examines the mechanisms by which viruses avoid host immune responses.